Susan Branford, Rebecca Lawrence^*, Linda Fletcher^*, Chani Field^*, Zbigniew Rudzki^* and Timothy Hughes

Institute of Medical & Veterinary Science, Adelaide, Australia

Dragana Milojkovic^*, Marco Bua^*, Jane F Apperley^*, Kasia Kozlowski^*, Jamshid Sorori^*, Letizia Foroni^*, Alistair Reid^*, Jiri Pavlu^*, Katy Rezvani^*, Francesco Dazzi^*, Eduardo Olavarria^*, Matthias Klammer^*, John M Goldman^* and David Marin

Department of Hematology, Imperial College London, Hammersmith Hospital, London, United Kingdom

Martin C. Müller, MD^1*, Benjamin Hanfstein, MD^1*, Philipp Erben, MD^1*, Susanne Schnittger, PhD², Susanne Saussele, MD^1*, Armin Leitner, MD^1*, Ulrike Proetel, MD^1*, Michael Lauseker^3*, Markus Pfirrmann, PhD^3*, Gerhard Ehninger, MD⁴, Thomas Fischer, MD^5*, Joerg Hasford, MD^3*, Dieter K. Hossfeld, MD, PhD^6*, Hans Jochem Kolb, MD⁷, Stefan W Krause, MD^8*, Christoph Nerl, MD^9*, Hans Pralle, MD^10*, Alois Gratwohl, MD¹¹, Andreas Tobler, MD¹², Ruediger Hehlmann, MD¹, Andreas Hochhaus, MD¹ and The German CML Study Group^1*

¹Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
²MLL, München, Germany
³IBE, München, Germany
⁴1. Medizinische Klinik, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
⁵3. Medizinische Klinik, Universitätsklinikum, Mainz, Germany
⁶Onkologische Schwerpunktpraxis Lerchenfeld, Hamburg, Germany
⁷3. Medizinische Klinik, Transplantationseinheit, München, Germany
⁸Medizinische Klinik 5, Universitätsklinikum, Erlangen, Germany
⁹Krankenhaus Schwabing, München, Germany
¹⁰Medizinische Klinik IV, Giessen, Germany
¹¹Universitätsspital, Basel, Switzerland
¹²Department of Hematology, Inselspital, Bern, Switzerland

Timothy P Hughes, MD^1*, Andreas Hochhaus, MD², Susan Branford, PhD³, Martin C Müller, MD^4*, Letizia Foroni, MD, PhD, FRCPath^5*, Brian J. Druker, MD⁶, François Guilhot, MD⁷, Richard A. Larson, MD⁸, Stephen G O'Brien, MD, PhD^9*, Roger J. Waltzman, MD¹⁰, Manisha Mone, PhD^11*, Elisabeth Wehrle, PhD^12*, Jerald P. Radich, MD^13* and John M. Goldman, MD^14*

¹Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
²Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
³Institute of Medical & Veterinary Science, Adelaide, Australia
⁴Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
⁵Department of Haematology, Imperial College, London, United Kingdom
⁶Oregon Health & Science University Cancer Institute, Portland, OR
⁷Clinical Investigational Centre INSERM 802, CHU de Poitiers, Poitiers, France
⁸University of Chicago, Chicago, IL
⁹University of Newcastle, Newcastle, United Kingdom
¹⁰Global Medical Affairs, Novartis Pharma. Corporation, Florham Park, NJ
¹¹Novartis Pharmaceuticals, Florham Park, NJ
¹²Novartis Pharma AG, Basel, Switzerland
¹³Fred Hutchinson Cancer Research Ctr., Seattle, WA
¹⁴Department of Haematology, Hammersmith Hospital, London, United Kingdom

Jorge Cortes, MD¹, Michele Baccarani, MD^2*, François Guilhot, MD³, Brian J. Druker, MD⁴, Susan Branford, PhD^5*, Dong-Wook Kim, MD, PhD⁶, Fabrizio Pane, MD^7*, Marc Rudoltz, MD⁸, Richard Yu^9*, LaTonya Collins, RN, BSN^8*, Tillmann Krahnke, PhD^10*, Jerald P. Radich, MD^11* and Timothy P Hughes, MD^12*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Institute of Hematology and Medical OncologySeragnoli, Bologna, Italy
³Clinical Investigational Centre INSERM 802, CHU de Poitiers, Poitiers, France
⁴Oregon Health & Science University, Portland, OR
⁵Division of Molecular Pathology, Institute of Medical & Veterinary Science, Adelaide, Australia
⁶Division of Hematology, St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
⁷CEINGE- Biotecnologie Avanzate, University of Naples Federico II, Naples, Italy
⁸Novartis Pharmaceutical, Inc., Florham Park, NJ
⁹Novartis, East Hanover, NJ
¹⁰B&sr, Novartis Pharmaceuticals
¹¹Fred Hutchinson Cancer Research Ctr., Seattle, WA
¹²Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia

Stefan Balabanov, MD/PhD^1*, Thoma Wilhelm, PhD^1*, Simone Venz, PhD^2*, Christine Barret^1*, Gunhild Keller, MD^1*, Mirja Bernhardt^1*, Artur Gontarewicz, MD^1*, Melanie Braig, PhD^1*, Reinhard Walther, PhD^2* and Tim H. Brummendorf, MD¹

¹Klinik für Onkologie und Hämatologie, Hubertus-Wald-Tumorzentrum-Universitäres Cancer Center Hamburg (UCCH), University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany
²Institut für Medizinische Biochemie und Molekularbiologie, Ernst-Moritz-Arndt Universität Greifswald, Greifswald